Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
0.551 USD | +0.95% | -17.72% | +7.51% |
05-09 | Earnings Flash (ATRA) ATARA BIOTHERAPEUTICS Reports Q1 Revenue $27.4M | MT |
04-01 | Stifel Adjusts Atara Biotherapeutics Price Target to $2.30 From $4.80, Maintains Hold Rating | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+7.51% | 65.72M | |
+3.26% | 108B | |
+11.19% | 104B | |
+1.28% | 22.33B | |
-12.77% | 22.19B | |
-7.05% | 18.69B | |
-38.36% | 17.74B | |
-9.61% | 17.64B | |
+4.45% | 14.05B | |
+34.81% | 12.51B |
- Stock Market
- Equities
- ATRA Stock
- News Atara Biotherapeutics, Inc.
- Transcript : Atara Biotherapeutics, Inc. Presents at J.P. Morgan 42nd Annual Healthcare Conference 2024, Jan-11-2024 09